These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 31966507

  • 21. MicroRNA-485-5p reduces O-GlcNAcylation of Bmi-1 and inhibits colorectal cancer proliferation.
    Chai Y, Du Y, Zhang S, Xiao J, Luo Z, He F, Huang K.
    Exp Cell Res; 2018 Jul 01; 368(1):111-118. PubMed ID: 29680296
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
    Wang G, Fang X, Han M, Wang X, Huang Q.
    Int J Mol Med; 2018 Mar 01; 41(3):1740-1748. PubMed ID: 29328362
    [Abstract] [Full Text] [Related]

  • 23. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H, Yin Y, Hu Y, Feng Y, Bian Z, Yao S, Li M, You Q, Huang Z.
    Pathol Res Pract; 2016 Jul 01; 212(7):643-9. PubMed ID: 27173050
    [Abstract] [Full Text] [Related]

  • 24. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H, Dai S, Zhen T, Shi H, Zhang F, Yang Y, Kang L, Liang Y, Han A.
    Eur J Cancer; 2014 Apr 01; 50(6):1207-21. PubMed ID: 24412052
    [Abstract] [Full Text] [Related]

  • 25. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu XY, Yu ZW, Jia YH, Bai XF, Li L, Liu YL, Cui BB.
    Mol Cancer; 2017 Jan 13; 16(1):9. PubMed ID: 28086904
    [Abstract] [Full Text] [Related]

  • 26. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.
    Lu L, Cai M, Peng M, Wang F, Zhai X.
    Cancer Manag Res; 2019 Jan 13; 11():1805-1816. PubMed ID: 30863186
    [Abstract] [Full Text] [Related]

  • 27. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.
    Lu D, Yao Q, Zhan C, Le-Meng Z, Liu H, Cai Y, Tu C, Li X, Zou Y, Zhang S.
    Oncotarget; 2017 Apr 04; 8(14):22674-22684. PubMed ID: 28186967
    [Abstract] [Full Text] [Related]

  • 29. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
    Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai S, Wang Z, Liu J, Cai G.
    Sci Rep; 2016 May 31; 6():27157. PubMed ID: 27244080
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I, Celik OI.
    Tumour Biol; 2016 May 31; 37(5):6637-45. PubMed ID: 26643896
    [Abstract] [Full Text] [Related]

  • 32. The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
    Zhao L, Yu H, Yi S, Peng X, Su P, Xiao Z, Liu R, Tang A, Li X, Liu F, Shen S.
    Oncotarget; 2016 Jul 19; 7(29):45370-45384. PubMed ID: 27248318
    [Abstract] [Full Text] [Related]

  • 33. miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma.
    Liu C, Li M, Hu Y, Shi N, Yu H, Liu H, Lian H.
    Onco Targets Ther; 2016 Jul 19; 9():2865-71. PubMed ID: 27284245
    [Abstract] [Full Text] [Related]

  • 34. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D, Lin B, Zhang X, Peng Y, Ye Z, Ma Y, Liang Y, Cao L, Li X, Li R, Sun L, Liu Q, Wu J, Zhou K, Zeng J.
    Oncotarget; 2017 Jul 25; 8(30):49807-49823. PubMed ID: 28591704
    [Abstract] [Full Text] [Related]

  • 35. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3.
    Yang L, Men WL, Yan KM, Tie J, Nie YZ, Xiao HJ.
    Eur Rev Med Pharmacol Sci; 2018 Aug 25; 22(15):4837-4845. PubMed ID: 30070320
    [Abstract] [Full Text] [Related]

  • 36. miR-19-5p Enhances Tumorigenesis in Human Colorectal Cancer Cells by Targeting TSPYL5.
    Huang C, Luo H.
    DNA Cell Biol; 2018 Jan 25; 37(1):23-30. PubMed ID: 29240449
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).
    Li S, Liu Z, Fang XD, Wang XY, Fei BY.
    Front Oncol; 2019 Jan 25; 9():495. PubMed ID: 31245295
    [Abstract] [Full Text] [Related]

  • 38. The Role of MicroRNA-1207-5p in Colorectal Cancer.
    Wang X, Wu X.
    Clin Lab; 2017 Nov 01; 63(11):1875-1882. PubMed ID: 29226644
    [Abstract] [Full Text] [Related]

  • 39. miR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer.
    Jin Y, Jiang Z, Guan X, Chen Y, Tang Q, Wang G, Wang X.
    DNA Cell Biol; 2016 May 01; 35(5):249-56. PubMed ID: 26845645
    [Abstract] [Full Text] [Related]

  • 40. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation.
    Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z.
    Oncotarget; 2015 Nov 10; 6(35):37544-56. PubMed ID: 26462034
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.